Ablation of atrial fibrillation in patients with heart failure deserves more than a IIb guidelines recommendation

J Cardiovasc Electrophysiol. 2019 Sep;30(9):1412-1415. doi: 10.1111/jce.14002. Epub 2019 Jun 4.

Abstract

The current evidence and guidelines for rhythm management of AF in HFrEF were examined. We propose updates of rhythm management (catheter ablation and antiarrhythmic drugs) of AF in HFrEF incorporating this most uptodate evidence.

Keywords: ablation; atrial fibrillation; guidelines; heart failure; mortality.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Action Potentials
  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Arrhythmia Agents / therapeutic use*
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / mortality
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / therapy*
  • Catheter Ablation / adverse effects
  • Catheter Ablation / standards*
  • Consensus
  • Evidence-Based Medicine / standards*
  • Health Status
  • Heart Failure / diagnosis
  • Heart Failure / mortality
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Heart Rate / drug effects*
  • Humans
  • Practice Guidelines as Topic / standards*
  • Recovery of Function
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents